Laszlo Dosa


Creation of retinochoroidal anastomosis may help those with CRVO

Mexico City-Surgical treatment of central retinal vein occlusion (CRVO) by the creation of retinochoroidal anastomosis (RCA) may become an effective therapy for some patients with CRVO, according to Hugo Quiroz-Mercado, MD.

FDT perimetry a better test of ganglion cell loss

Fort Lauderdale, FL-Frequency doubling technology (FDT) perimetry appears to be a more sensitive visual field test for ganglion cell loss than traditional testing methods, according to Christopher A. Girkin, MD.

Benefits of bifocal contact lens may depend on aberrations

Fort Lauderdale, FL-Researchers at the University of Houston College of Optometry are trying to understand why certain individuals do not gain bifocal vision with a multizone bifocal contact lens. The reason could be dependent on an individual's optical aberrations, noted Joy A. Martin, an OD and PhD student, who spoke during the annual meeting of the Association for Research in Vision and Ophthalmology.

Anti-VEGF therapy holds promise for CNV in AMD

July 01, 2002

Fort Lauderdale, FL-Anti-vascular endothelial growth factor (anti-VEGF) therapy is a promising treatment of neovascularization brought on by various ocular diseases, including age-related macular degeneration (AMD), according to Lawrence J. Singerman, MD.

Intravitreal triamcinolone for AMD appears promising, but more studies needed

July 01, 2002

Fort Lauderdale, FL-Intravitreal triamcinolone appears to inhibit the growth of choroidal neovascularization (CNV) and reduce subretinal fluid in the short term, but it needs further evaluation, ac-cording to Mark Gillies, MB, BS, PhD.

AREDS supports the use of nutritional supplements for AMD

July 01, 2002

Fort Lauderdale, FL-Of the nearly 60 million people in the United States over age 55, 8 million are estimated to be at high risk for advanced age-related macular degeneration (AMD), making it an important public health concern. However, nutritional supplements may be helpful to reduce this risk, according to the Age-Related Eye Disease Study (AREDS).